Key result
Transthoracic echocardiography using the Teichholz formula overestimated left ventricular mass index compared to cardiac magnetic resonance imaging by a mean of 15.9 g/m2, though this overestimation was less severe than that seen with the ASE formula.
Why the study?
LVH is highly prevalent in hemodialysis patients and predicts cardiovascular events, but echocardiography tends to overestimate LVMI compared to CMR.
Does transthoracic echocardiography using the Teichholz formula improve the accuracy of left ventricular mass index quantification compared to the ASE formula when referenced to CMR in hemodialysis patients?
Cross-Sectional (n=95)
Blinded
Yes
Does transthoracic echocardiography using the Teichholz formula improve the accuracy of left ventricular mass index quantification compared to the ASE formula when referenced to CMR in hemodialysis patients?
In hemodialysis patients, the Teichholz formula provides a more accurate echocardiographic estimation of left ventricular mass index than the standard ASE formula, particularly in patients with left ventricular hypertrophy.
Answers are grounded in this paper and cite their sources.
Teichholz formula yields less biased LVMI estimates than ASE in hemodialysis patients; leaves open prospective validation against outcomes.
BACKGROUND: Left ventricular hypertrophy (LVH), defined by the left ventricular mass index (LVMI), is highly prevalent in hemodialysis patients and a strong independent predictor of cardiovascular events. Compared to cardiac magnetic resonance imaging (CMR), echocardiography tends to overestimate the LVMI. Here, we evaluate the diagnostic performance of transthoracic echocardiography (TTE) compared to CMR regarding the assessment of LVMI in hemodialysis patients. METHODS: TTR and CMR data for 95 hemodialysis patients who participated in the MiREnDa trial were analyzed. The LVMI was calculated by two-dimensional (2D) TTE-guided M-mode measurements employing the American Society of Echocardiography (ASE) and Teichholz (Th) formulas, which were compared to the reference method, CMR. We found greater LVMI overestimation in patients with LVH using the ASE formula compared to the Th formula. Stratification of patients into CMR LVMI quartiles showed a continuous decrease in ∆LVMI with increasing CMR LVMI quartiles for the Th formula (p < 0.001) but not for the ASE formula (p = 0.772). Bland-Altman analysis showed that the Th formula had a constant bias independent of LVMI. Both methods had good discrimination ability for the detection of LVH (ROC-AUC: 0.819 (0.737-0.901) and 0.808 (0.723-0.892) for Th and ASE, respectively). CONCLUSIONS: The ASE and Th formulas overestimate LVMI in hemodialysis patients. However, the overestimation is less with the Th formula, particularly with increasing LVMI. The results suggest that the Th formula should be preferred for measurement of LVMI in chronic hemodialysis patients. TRIAL REGISTRATION: The data was derived from the following clinical trial: NCT01691053 , registered on 19 September 2012 before enrollment of the first participant.
No takes yet. Share an insight, caveat, or question.
Grebe et al. (2020) conducted a cross-sectional in Hemodialysis (n=95). Transthoracic echocardiography (Teichholz formula) vs. Cardiac magnetic resonance imaging (CMR) was evaluated on Mean difference in left ventricular mass index (LVMI) compared to CMR (p=<0.001). Transthoracic echocardiography using the Teichholz formula overestimated left ventricular mass index compared to cardiac magnetic resonance imaging by a mean of 15.9 g/m2, though this overestimation was less severe than that seen with the ASE formula.
Synapse has enriched 10 related papers. Consider them for comparative context: